Immunovant will end cutaneous lupus work after a 57-patient IMVT-1402 trial missed its Week 12 skin disease endpoint.

PEJ and the Westinghouse-Bechtel team aim to finish EPC talks by end-2026 for a planned 3,750 MWe Polish nuclear plant.

NexGold's Sept. 23 Goldlund update reports 14.07 grams per tonne gold over 7 metres, with 31,971 metres drilled toward a ...

Optimi Health quality released 5 mg psilocybin capsules for a Canadian Phase 2 depression trial of up to 200 people and Australian clinics.

Amgen says OASIZ 301 met its Week 48 endpoint in a study planned for about 621 patients; the treatment gap remains unpublished.

Samsung C&T's Sept. 21 term sheet caps a mixed investment and services package at US$100M for Kairos Power's Hermes 2, pending approvals.

CBAK signed a Nanjing agreement for 12 GWh of planned annual capacity, while financing gates the new lines and a separate 6 GWh expansion is due in 2026.

Ines Halvorsen keeps Mugglehead's energy ledger: power, nuclear, hydrogen, transmission and storage, and the listed companies ...

Ivanhoe Electric's Santa Cruz study sets US$1.43 billion in initial capital and US$1.5 billion in after-tax NPV, with first cathode targeted for 2029.

Alpha Compute signed binding agreements on Sept. 22 to buy 300 acres and more than 75 Pennsylvania oil and gas wells at a ...

Canopy Growth will supply four Canadian-grown flower strains to UK distributor GROW Group, adding to a C$9.6M international cannabis business.

Meridian Mining's Cabaçal study estimates US$322 million in initial capital and a 0.9-year payback, with financing and permitting pending.